Walgreens Boots Alliance (NASDAQ:WBA) Given New $7.00 Price Target at Morgan Stanley

Walgreens Boots Alliance (NASDAQ:WBA – Free Report) had its price objective reduced by Morgan Stanley from $9.00 to $7.00 in a research report report published on Friday, Benzinga reports. Morgan Stanley currently has an underweight rating on the pharmacy operator’s stock. A number of other research firms also recently weighed in on WBA. JPMorgan Chase […]

Leave a Reply

Your email address will not be published.

Previous post Cwm LLC Has $7.51 Million Position in CME Group Inc. (NASDAQ:CME)
Next post TORM (NASDAQ:TRMD) Shares Down 0% – Here’s Why